|Articles|April 9, 2008

Drug Topics survey finds most think FDA needs more resources to do its job well

A Drug Topics survey finds that most think FDA could use more funding to redress its deficiencies.

Is the Food & Drug Administration doing a good job ensuring our drug safety? Drug Topics posed this question in its a

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Latest CME

On-Demand Virtual Symposium

Expanding the Role of Long-Acting Injectables in Optimizing Schizophrenia Management

1.5 Credits / Psychiatry

On-Demand Virtual Symposium

VMAT2 Inhibitors for Long-Term Success in Tardive Dyskinesia

1.5 Credits / Neurology, Psychiatry

On-Demand Virtual Symposium

Shifting Perspectives in Treatment-Resistant Depression: Novel Therapies and Patient-Centered Care

1.5 Credits / Psychiatry

On-Demand Webinar

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes

1.0 Credits / Breast Cancer, Oncology, Women's Health

On-Demand Webinar

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

0.75 Credits / Breast Cancer, Oncology, Women's Health

On-Demand Webinar

Optimizing Therapy in HR+/HER2-Negative Metastatic Breast Cancer: Navigating Novel Treatments and Personalized Care

1.0 Credits / Breast Cancer, Oncology, Women's Health

On-Demand Webinar

Optimizing HER2-Directed Therapy in Metastatic Breast Cancer: From HER2-Positive to HER2-Ultralow

1.5 Credit / Breast Cancer, Oncology, Women's Health

On-Demand Webinar

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

1.0 Credits / Neurology

On-Demand Webinar

Expert Insights on the Horizon of HER2-Directed Therapy

0.5 Credit / Breast Cancer, Oncology, Women's Health

On-Demand Virtual Symposium

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

1.5 Credit / Immunology, Pulmonology/Respiratory

On-Demand Virtual Symposium

Type 2 Inflammation in Focus: Advancing Pediatric Atopic Dermatitis Care With Biologic Therapies

1.5 Credits / Dermatology, Immunology

On-Demand Virtual Symposium

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

1.5 Credits / Immunology

On-Demand Virtual Symposium

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

1.5 Credits / Immunology, Pulmonology/Respiratory

On-Demand Virtual Symposium

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

1.0 Credit

Online Article

Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies

2.0 Credits / Hematologic Cancer, Oncology

On-Demand Panel Discussion

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

1.5 Credit / Hematology, Rare Diseases

Online Article

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

2.0 Credits / Lung Cancer, Oncology, Pulmonology/Respiratory

Online Article

Payment for Pharmacist Services: 2025 Update

1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law

On-Demand Webinar

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

1.0 Credit / Immunology, Rare Diseases

On-Demand Webinar

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

1.0 Credit / Oncology

On-Demand Webinar

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

1.0 Credit / Nephrology

On-Demand Webinar

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

1.75 Credit / Hematologic Cancer, Hematology, Oncology

On-Demand Webinar

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

1.0 Credits / Dermatology, Immunology

Online Article

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

2.0 Credits / Immunology, Rare Diseases, Hematology

On-Demand Webinar

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

1.0 Credit / Immunology, Neurology, Rare Diseases

$Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists$

On-Demand Webinar

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

1.25 Credits / Hematologic Cancer, Oncology

Drug Topics survey finds most think FDA needs more resources to do its job well

Related Content

Pharmacy Law Lowdown: Copay Collection Compliance

Postpartum Mothers Favor Bedtime Stopping Rule Over Stricter Chrononutrition Approaches

ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain

What’s Next for Pneumococcal Vaccination? An Expert Weighs In

Vaccine Policy in Flux: Stories Pharmacists Need to Follow

Latest CME

Expanding the Role of Long-Acting Injectables in Optimizing Schizophrenia Management

VMAT2 Inhibitors for Long-Term Success in Tardive Dyskinesia

Shifting Perspectives in Treatment-Resistant Depression: Novel Therapies and Patient-Centered Care

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

Optimizing Therapy in HR+/HER2-Negative Metastatic Breast Cancer: Navigating Novel Treatments and Personalized Care

Optimizing HER2-Directed Therapy in Metastatic Breast Cancer: From HER2-Positive to HER2-Ultralow

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

Expert Insights on the Horizon of HER2-Directed Therapy

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

Type 2 Inflammation in Focus: Advancing Pediatric Atopic Dermatitis Care With Biologic Therapies

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

Payment for Pharmacist Services: 2025 Update

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Trending on Drug Topics

New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages

Vaccine Policy in Flux: Stories Pharmacists Need to Follow

Pharmacists Are Essential Drivers of Opioid Stewardship Programs

Q&A: Pharmacists Help Patients Navigate Pneumococcal Vaccine Options

Pharmacists Want Prescribing Authority With Proper Training, Support